Management of neurocytomas - Case report and review of the literature

Citation
Dm. Brown et al., Management of neurocytomas - Case report and review of the literature, AM J CL ONC, 24(3), 2001, pp. 272-278
Citations number
26
Categorie Soggetti
Oncology
Journal title
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
ISSN journal
02773732 → ACNP
Volume
24
Issue
3
Year of publication
2001
Pages
272 - 278
Database
ISI
SICI code
0277-3732(200106)24:3<272:MON-CR>2.0.ZU;2-W
Abstract
The purpose of this report is to review the available Literature on the pre sentation, pathology, and treatment of central nervous system (CNS) neurocy tomas. A case report of an extraventricular neurocytoma is presented along with a comprehensive literature search of patients with a diagnosis of CNS neurocytoma. CNS neurocytomas are rare neoplasms, with fewer than 240 cases reported in the literature. The majority of neurocytomas are found in the ventricular system of the brain. Immunohistochemistry is frequently used to help distinguish this tumor from other CNS neoplasms. MIB-1 proliferation index is commonly used in an attempt to predict biologic behavior. Little i s known about the management of patients with this tumor, because most repo rts are from the pathologic literature and contain sparse information regar ding clinical management. Neurocytomas are rare CNS tumors with varied biol ogic behavior. MIB-1 index may help direct adjuvant therapy. An excellent p rognosis can be expected if a gross total resection is achieved. Postoperat ive radiation therapy CRT) may be considered after subtotal resection. Othe rwise, RT is an option for medically inoperable or recurrent disease.